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ABSTRACT
The major objective of this research effort is the temperature driven growth of protein crystals in large
batches in the microgravity environment of space. Pharmaceutical houses are developing protein
products for patient care, for example, human insulin, human growth hormone, interferons and tissue
plasminogen activator or TPA, the clot buster for heart attack victims. Except for insulin, these are
very high value products; they are extremely potent in small quantities and have a great value per
gram of material. It is feasible that microgravity crystallization can be a cost recoverable, economi-
cally sound final processing step in their manufacture.
Large scale protein crystal growth in microgravity has significant advantages from the basic science
and the applied science standpoints. Crystal growth can proceed unhindered due to lack of surface
effects. Dynamic control is possible and relatively easy. The method has the potential to yield large
quantities of pure crystalline product. Crystallization is a time honored procedure for purifying
organic materials and microgravity crystallization could be the final step to remove trace impurities
from high value protein pharmaceuticals. In addition, microgravity grown crystals could be the final
formulation for those medicines that need to be administered in a timed release fashion. Long lasting
insulin, insulin lente, is such a product. Also crystalline protein pharmaceuticals are more stable for
long-term storage. Temperature, as the initiation step, has certain advantages. Again, dynamic
control of the crystallization process is possible and easy. A temperature step is non-invasive and is
the most subtle way to control protein solubility and therefore crystallization. Seeding is not
necessary. Changes in protein and precipitant concentrations and pH are not necessary. Finally, this
method represents a new way to crystallize proteins in space that takes advantage of the unique
microgravity environment.
The hardware design for the Protein Crystallization Facility (PCF) entails four polysulfone cylinders
(500, 200, 100, 50 ml total volume) of different heights and same diameters. The aluminum cap of
each cylinder is apposed to the heating element of the RflM and the temperature is decreased from
40°C to 22°C early in the mission for insulin, the sample used for STS-37 and STS-3. The four
cylinder sizes resulted in four different temperature gradients. On STS-37. the temperature was
ramped down in four steps over 23 hours, while on STS-43 the ramp was in one step.
The results from these two flights showed that the hardware performed perfectly, many crystals were
produced and they were much larger than their ground grown controls. Morphometric analysis was
done on over 4,000 crystals to establish crystal size, size distribution and relative size. Space grown
crystals were remarkably larger than their earth grown counterparts and crystal size was a function
of PCF volume. For example, for the largest volume PCF (500 ml) from STS-37, the space crystals
were 10 times bigger than controls while for the smallest volume (50 ml) they were 2 times bigger.
That size distribution for the space grown crystals was a function of PCF volume may indicate that
ultimate size was a function of temperature gradient. Since the insulin protein concentration was very
low, 0.4 mg/ml, the size distribution could also be following the total amount of protein in each of
the PCFs. X-ray analysis showed that the bigger space grown insulin crystals diffracted to higher
resolution than their ground grown controls. When the data were normalized for size, they still
indicated that the space crystals were better than the ground crystals. 5311
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OBJECTIVES
• To grow protein crystals in large batches
• To use temperature as the means to
initiate and control protein crystal growth
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ADVANTAGES OF LARGE SCALE
PROTEIN CRYSTAL GROWTH
• No surface effects to interfere with
crystal growth
• Easy dynamic control is possible
• Yields large quantities of large, very pure
crystals
• Purity of protein is achieved
• Uniformity of size of protein crystal
is possible
• Patentability is enhanced and this
stimulates commercial interest
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ADVANTAGES OF TEMPERATURE IN
PROTEIN CRYSTAL GROWTH
• Dynamic control is possible
• Non-invasive, most subtle way to control
protein solubility
• No seeding is necessary
• No changes in [protein], [precipitant], or
pH are necessary
• Represents a new way to crystallize
proteins that takes advantage of
microgravity environment
PROTEIN CRYSTALLIZATION
(PCF)
HARDWARE DESIGN
FACILITY
Polysulfone with neoprene O-rings
4 cylinders: 500ml,200ml,10Oml,50ml
All have the same diameter with different
heights
The metal cap of each cylinder is
apposed to the heating element of the
R/IM and the temperature is decreased
from 40C to 22C early in flight
Insulation is around each cylinder
The 4 sizes will result in 4 different
temperature gradients
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TEMPERATURE
FACILITY
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PROTEIN TO BE CRYSTALLIZED
• Insulin, at 0.4 mg/ml, in phosphate buffer,
will be the first protein to fly in the PCF
• The temperature is decreased from
40C to 22C early in the flight
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